Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

265.53 -1.20 (-0.45%)
Official Closing Price Updated: 7:00 PM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now ↗
But is that performance sustainable? 
Via The Motley Fool
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth ↗
Johnson & Johnson's revenue has grown modestly while Eli Lilly's revenue has nearly doubled in two years, narrowing a once-wide gap. 
Via The Motley Fool
Chips Sell First, Ask Questions Later - And SK Hynix Just Handed Them the Answer ↗
Via Chartmill
Johnson & Johnson (NYSE:JNJ) Is a Top Dividend Quality Stock for Reliable Income ↗
Via Chartmill
News headline image
Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest ↗
Johnson & Johnson reached a $5.5 billion agreement to resolve remaining federal and state talc litigation over ovarian cancer claims. 
Via Benzinga
News headline image
Stock Market Today: Dow Jones Futures Gain, Nasdaq 100 Declines as Oil Slips Ahead of Trump's Meetings With Zelensky and Netanyahu—Boeing, Coca-Cola, Johnson & Johnson in Focus ↗
U.S. stock futures were mixed on Tuesday, as the Dow Jones index gained but the S&P 500 and Nasdaq 100 indices declined. 
Via Benzinga
Topics Government Stocks
News headline image
If I Only Had $500 to Invest, This Is the ETF I'd Buy Right Now ↗
This value ETF offers a great value for investors right now. 
Via The Motley Fool
Topics ETFs Economy
News headline image
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson? ↗
Both have very promising futures. 
Via The Motley Fool
Which dow jones stocks are moving on Friday? ↗
Via Chartmill
Explore the top gainers and losers within the dow jones index in today's session. ↗
Via Chartmill
News headline image
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It ↗
A name that's often ignored by investors due to its limited historic growth is evolving into a solid income-growth prospect. 
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Top Growth Stocks to Buy Right Now Without Any Hesitation ↗
There are plenty of reasons to love these companies. 
Via The Motley Fool
These dow jones stocks are moving in today's session ↗
Via Chartmill
What's going on in today's session: dow jones movers ↗
Via Chartmill
News headline image
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System ↗
FDA grants De Novo authorization for Johnson & Johnson's OTTAVA robotic surgical system for general surgery procedures. 
Via Benzinga
These dow jones stocks are moving in today's session ↗
Via Chartmill
Which dow jones stocks are moving on Tuesday? ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Monday. ↗
Via Chartmill
News headline image
5 Stocks Quietly Trading Near All-Time Highs While Everyone Watches the AI Drama ↗
While AI stocks correct, Johnson & Johnson, Altria, Coca-Cola, JPMorgan, and Apple are quietly trading near 52-week or all-time highs ahead of earnings. 
Via MarketBeat
Topics Artificial Intelligence Initial Public Offering
News headline image
PJP vs. IYH: Which Healthcare ETF Is the Better Buy? ↗
PJP delivered a higher return over the past year -- but IYH charges lower fees and pays a higher dividend yield. 
Via The Motley Fool
Topics ETFs
News headline image
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report? ↗
J&J has more than 28 sources of blockbuster revenue. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
My 2 Favorite Dividend Kings to Buy Right Now ↗
They can help stabilize your portfolio in these otherwise volatile times. 
Via The Motley Fool
Topics Intellectual Property
News headline image
MarketBeat Week in Review – 07/13- 07/17 ↗
A tech selloff hit the S&P 500 and NASDAQ this week while energy and financial stocks gained; MarketBeat analysts recap Micron, Netflix, Broadcom, Apple and more ahead of Alphabet's earnings. 
Via MarketBeat
Topics Artificial Intelligence Economy Stocks
These dow jones stocks are moving in today's session ↗
Via Chartmill
Top dow jones movers in Friday's session ↗
Via Chartmill
News headline image
Johnson & Johnson Posts Upbeat Q2: IM Momentum Building Into 2027, Says Bullish Analyst ↗
The reasons why RBC Capital Markets maintains its stock rating. 
Via Benzinga
News headline image
Johnson & Johnson vs. Eli Lilly and: Which Pharma Giant Stock Is a Better Buy in 2026? ↗
One generates steady cash flow with a lower valuation; the other is growing at 45% but carries higher leverage. 
Via The Motley Fool
News headline image
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH? ↗
IHE concentrates on giants such as Johnson & Johnson and Eli Lilly, while XPH spreads risk across 65 holdings with different volatility profiles. 
Via The Motley Fool
Topics ETFs
News headline image
Full Transcript: Johnson & Johnson Q2 2026 Earnings Call ↗
Johnson & Johnson (NYSE:JNJ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.